Fontem Ventures Acquires Nerudia
Thursday 9 November 2017
Fontem Ventures, owner of market leading electronic vapour brand blu, has acquired Nerudia.
Based in Liverpool UK, Nerudia was established in 2013 by David Newns and Chris Lord who have joined the management team at Fontem Ventures as co-heads of Research & Development.
The acquisition of Nerudia further enhances Fontem’s capabilities in innovation and regulatory compliance, and adds significant GMP manufacturing capacity at Nerudia’s MHRA (Medicines and Healthcare products Regulatory Agency) licenced facility.
Titus Wouda Kuipers, Chief Executive of Fontem Ventures, commented ‘In blu, we have one of the best e-vapour brands in the world and we continue to focus on improving the consumer experience. Vaping technology is continually evolving and in October 2017 we substantially enhanced our technical capabilities with the acquisition of the e-vapour innovation business Nerudia’.
David Newns, Nerudia co-founder, said ‘We are delighted to become part of the Fontem Ventures family and the acquisition is an incredible milestone for our business and testament to the team that we have built. We will be expanding our current team and capabilities in Liverpool, and are excited about the potential that this unlocks for us in the years to come’.
For any media enquiries please contact Guy Hendricks at firstname.lastname@example.org